Wednesday, Jul 29, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Dr Reddys Icici Lombard Partner To Pilot Launch Cashless Digital Health Solution

Dr Reddy’s, ICICI Lombard partner to pilot launch cashless digital health solution

Multi-service mobile app platform brings together doctors, laboratories & diagnostics, pharmacies, and insurance for a one-stop cashless and seamless outpatient user experience

By Telangana Today
Published Date - 27 July 2021, 05:07 PM
Dr Reddy’s, ICICI Lombard partner to pilot launch cashless digital health solution
whatsapp facebook twitter telegram

Hyderabad: SVAAS Wellness, a wholly-owned subsidiary of Dr Reddy’s Laboratories and ICICI Lombard General Insurance Company, entered into a partnership for the pilot launch of a first-of-its-kind cashless outpatient offering in India.

The partnership marks the launch of Dr Reddy’s digital health solution ‘SVAAS’ and demonstrates ICICI Lombard’s deeper foray into the wellness space. For Dr Reddy’s, it will bring together four key touch points in the journey of outpatient healthcare and wellness– doctor consultations, pathology laboratories and diagnostic services, pharmacies, and insurance – through various suitable collaborations. For ICICI Lombard, it will enable it to offer its wellness solutions through its comprehensive ILTakeCare app to a larger set of health-conscious consumers.


To start with, these services will be provided in the cities of Hyderabad and Visakhapatnam. It will be scaled up to key metros and tier 1 cities in the coming months. As part of the pilot, these holistic offerings will be available through ICICI Lombard’s unique wellness and insurance related app, ILTakeCare.

The partnership combines the core strengths of SVAAS in the form of extensive healthcare professional networks with the established insurance and wellness-oriented solutions of ICICI Lombard. Users will benefit from cashless access to consultation from leading doctors and healthcare professionals across specialisations and geographies, pathology laboratories and diagnostic services, pharmacies, and a comprehensive support centre, all on a simple, easily accessible mobile platform.

It offers options of in-person as well as remote tele/video consultations, home sample collections and medicine deliveries, digital health record management and a comprehensive support and fulfilment system.

M V Ramana, CEO, Branded Markets (India & Emerging Markets), Dr Reddy’s, said, “Through our initiative called ‘SVAAS’—meaning ‘breath’—we will endeavour to go beyond traditional pharmaceutical offerings and provide a comprehensive but simplified healthcare solution to people in managing their healthcare needs. Beyond the pilot, we will aim to use our own SVAAS digital platform and work with multiple established partners.”

Alok Agarwal, ED, ICICI Lombard said, “For health insurance customers, this means not just providing them with the most efficient claim settlement experience. It goes further ahead by hand holding them in their journey to stay healthy and fit. To do so, we have introduced convenient solutions like ‘ILTakeCare’ a comprehensive, wellness and insurance-oriented app that offers multiple benefits to customers in a contactless way and at their fingertips.”


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

  • Follow Us :
  • Tags
  • cashless digital health solution
  • Dr Reddy’s Laboratories
  • ICICI Lombard General Insurance Company
  • SVAAS Wellness

Related News

  • Dr Reddy’s Q1 profit tumbles on semaglutide supply woes

    Dr Reddy’s Q1 profit tumbles on semaglutide supply woes

  • Dr Reddy’s launches oral semaglutide biosimilar Obeda in India

    Dr Reddy’s launches oral semaglutide biosimilar Obeda in India

  • Dr Reddy’s Q4 profit falls 86 per cent on weak North America sales

    Dr Reddy’s Q4 profit falls 86 per cent on weak North America sales

  • Dr Reddy’s Q3 profit dips 14 pc on weak US sales

    Dr Reddy’s Q3 profit dips 14 pc on weak US sales

Latest News

  • J&K LG Manoj Sinha participates in educational, spiritual events in Khammam

    5 mins ago
  • Delayed credit card repayment not misconduct, rules Telangana High Court

    13 mins ago
  • Telangana HC declines relief to IPS trainee in harassment case

    20 mins ago
  • Six-time offender held in gold scam by CCS Hyderabad

    34 mins ago
  • Hyderabad Rain: IT corridor junctions choke under rain and civic works

    41 mins ago
  • AICC steps in to rein in Telangana Congress amid growing rift

    53 mins ago
  • BMW to cut around 8,000 jobs in Germany by 2027 amid weak demand and EV transition

    58 mins ago
  • BRS MLC Sravan accuses govt colleges of withholding certificates of students

    60 mins ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam